BeOne Medicines Ltd. (ONC)
379.31
+7.33
(+1.97%)
USD |
NASDAQ |
Aug 25, 13:39
BeOne Medicines Total Liabilities (Quarterly) : 3.973B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.973B |
| March 31, 2026 | 3.765B |
| December 31, 2025 | 3.842B |
| September 30, 2025 | 3.474B |
| June 30, 2025 | 2.498B |
| March 31, 2025 | 2.312B |
| December 31, 2024 | 2.563B |
| September 30, 2024 | 2.362B |
| June 30, 2024 | 2.314B |
| March 31, 2024 | 2.274B |
| December 31, 2023 | 2.234B |
| September 30, 2023 | 1.728B |
| June 30, 2023 | 1.895B |
| March 31, 2023 | 1.762B |
| December 31, 2022 | 1.958B |
| September 30, 2022 | 2.033B |
| June 30, 2022 | 2.035B |
| March 31, 2022 | 2.092B |
| December 31, 2021 | 2.357B |
| September 30, 2021 | 1.883B |
| June 30, 2021 | 1.870B |
| March 31, 2021 | 1.770B |
| Date | Value |
|---|---|
| December 31, 2020 | 1.682B |
| September 30, 2020 | 1.222B |
| June 30, 2020 | 1.310B |
| March 31, 2020 | 1.195B |
| December 31, 2019 | 587.54M |
| September 30, 2019 | 550.42M |
| June 30, 2019 | 541.14M |
| March 31, 2019 | 510.78M |
| December 31, 2018 | 458.19M |
| September 30, 2018 | 390.94M |
| June 30, 2018 | 405.74M |
| March 31, 2018 | 327.58M |
| December 31, 2017 | 330.81M |
| September 30, 2017 | 284.57M |
| June 30, 2017 | 203.80M |
| March 31, 2017 | 68.31M |
| December 31, 2016 | 52.91M |
| September 30, 2016 | 47.59M |
| June 30, 2016 | 31.18M |
| March 31, 2016 | 22.13M |
| December 31, 2015 | 42.44M |
| September 30, 2015 | 35.53M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| CRISPR Therapeutics AG | 904.22M |
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| AC Immune SA | 142.85M |
| Idorsia Ltd. | 2.055B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.176B |
| Shareholders Equity (Quarterly) | 5.174B |
| Debt to Equity Ratio | 0.3961 |
| Current Ratio | 3.405 |
| Net Debt Paydown Yield | -0.71% |